WednesdayFeb 05, 2020 1:37 pm

QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) to Focus Clinical Efforts on Oncoprex(TM) in Combination with Osimertinib for Treatment of Non-Small Cell Lung Cancer

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, today provided a clinical update and focus for its Oncoprex(TM) immunogene therapy program for 2020. According to the update, Genprex will prioritize the development of Oncoprex in combination with osimertinib for the treatment of non-small cell lung cancer (“NSCLC”). Genprex, on January 14, 2020, received U.S Food and Drug Administration (“FDA”) Fast Track Designation for its Oncoprex immunogene therapy in combination with the EGFR tyrosine kinase inhibitor osimertinib (AstraZeneca’s Tagrisso(R), currently its highest grossing product) for the…

Continue Reading

WednesdayFeb 05, 2020 1:29 pm

QualityStocksNewsBreaks – LiveWire Ergogenics Inc. (LVVV) Enters Strategic Agreement with Specialty Grower QDG Agricultural

LiveWire Ergogenics (OTC: LVVV), a health and wellness company with a focus on special purpose real-estate acquisitions and the licensing and management of high-end and permitted facilities and operations to provide cannabis-based products and services in California, on Tuesday announced its entry into a definitive agreement with QDG Agricultural (“QDG”), an experienced and highly specialized cannabis production company, to begin construction for operation at its Estrella Ranch facility in Paso Robles, California. “With the demand for pure, organically grown and thoroughly tested cannabis products growing rapidly, we anticipate the handcrafted product that will be grown at our California ranch to…

Continue Reading

WednesdayFeb 05, 2020 12:32 pm

QualityStocksNewsBreaks – Neutra Corp. (NTRR) Secures New Round of Private Equity to Drive Vertical Integration

Neutra Corp. (OTC: NTRR) on Tuesday announced its January 1, 2020 receipt of a new round of private equity that it intends to use in its ongoing campaign to become a vertically integrated producer, manufacturer and distributor of hemp-based CBD health products. “This is a welcome event that strengthens our company and puts it in a better long-term position to compete and succeed in the marketplace,” Neutra CEO Sydney Jim said in the news release. “This funding round gives us the ability to pursue our strategies and goals, as well as potentially expand our vision for the future. We had…

Continue Reading

WednesdayFeb 05, 2020 12:22 pm

QualityStocksNewsBreaks – Standard Lithium Ltd. (TSX.V: SLL) (OTCQX: STLHF) (FRA: S5L) Increases Private Placement to $9M Based on Strong Interest

Standard Lithium (TSX.V: SLL) (OTCQX: STLHF) (FRA: S5L) on Tuesday announced that, owing to very strong interest, it will increase the size of its non-brokered private placement of special warrants (each, a “Special Warrant”) to accommodate the additional demand. According to the update, the Company now intends to offer up to 12,000,000 Special Warrants, each at a price of $0.75, for gross proceeds of up to $9,000,000. Standard Lithium intends to use net proceeds from the private placement to complete commissioning of its extraction demonstration plant in southern Arkansas, as well as to maintain existing property interests and for general…

Continue Reading

WednesdayFeb 05, 2020 11:24 am

QualityStocksNewsBreaks – Sigma Labs, Inc. (NASDAQ: SGLB) to Host Virtual Roadshow Webinar on February 6th

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, today announced its plans to host a virtual roadshow webinar at 4:30 PM ET on Thursday, February 6, 2020. According to the update, Sigma Labs newly appointed Executive Chairman Mark K. Ruport and CEO John Rice will be presenting an overview of the market opportunity and the company's strategy to accelerate its revenue growth. The webinar will include a presentation followed with a question and answer session. Interested parties can access the webinar by visiting http://ibn.fm/Il0IU or by dialing 1-877-407-9039 or 1-201-689-8470 (International)…

Continue Reading

WednesdayFeb 05, 2020 11:19 am

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Launches Innovative Culture Media for Growing Ovarian Tumor Cells in the Lab

Predictive Oncology (NASDAQ: POAI), together with its subsidiary, TumorGenesis, Inc., today announced that it has selected US Biological Corporation of Salem, Massachusetts as the manufacturer and distributor of its innovative culture media for growing ovarian tumor cells. TumorGenesis media are specially formulated to help researchers isolate and maintain the unique histological and basic biological signatures of heterogeneous ovarian cell types while growing them in the laboratory, unlike traditional cell culture media that select for one or two fast growing cell types. “Using these proprietary media our partners have identified 25 cell types from ovarian tumors, which to a large degree…

Continue Reading

WednesdayFeb 05, 2020 10:24 am

QualityStocksNewsBreaks – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Announces Receipt of $600K Purchase Order for 4G Rugged PoC Handset Devices

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF) today announced its receipt of a $600,000 purchase order for its 4G rugged PoC handset devices. “This is an exciting win for Siyata as it demonstrates the strong continual market demand for our Push-to-Talk over Cellular (“PoC”) rugged handsets,” Siyata Mobile CEO Marc Seelenfreund said in the news release. “Our rugged handset devices aim to provide customers with the convenience and ease of a rugged smartphone handset, while offering high speed LTE data services and a large PTT button for seamless communication between enterprise users.” To view the full press release, visit http://ibn.fm/9BoxL About…

Continue Reading

WednesdayFeb 05, 2020 10:15 am

QualityStocksNewsBreaks – HTC Extraction Systems’ (TSX.V: HTC) (OTCQB: HTPRF) Extraction Technology Selected for $20M Xprize Competition

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) today announced that HTC’s patented extraction technology has been selected to supply extracted CO2 for the prestigious $20 million NRG COSIA Carbon Xprize competition. According to the update, the four-and-a-half-year global Xprize competition challenges teams to transform the way the world addresses carbon dioxide (“CO2”) emissions through breakthrough circular carbon technologies that convert carbon dioxide emissions from power plants into valuable products. Ten teams from five countries were selected to advance to finals after passing a first-round evaluation based on the amount of CO2 converted into products, as well as the economic value,…

Continue Reading

WednesdayFeb 05, 2020 9:32 am

QualityStocksNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Subsidiary Modifies TerrAscend Canada Loan Terms

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, this morning announced that Canopy Rivers Corporation, a wholly-owned subsidiary of the company, has amended the terms of its recent US$10 million loan to TerrAscend Canada Inc., a wholly‑owned subsidiary of TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF). The loan, announced October 2, 2019, included the purchase of 13,243 units, each of which was comprised of: (i) one unsecured convertible debenture of TerrAscend Canada with a principal amount of C$1,000 (the "debentures"), and (ii) 25.2 common share purchase warrants to purchase common shares of TerrAscend with an exercise…

Continue Reading

TuesdayFeb 04, 2020 1:13 pm

QualityStocksNewsBreaks – Cannara Biotech Inc. (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB) Receives Cultivation License for Purpose-Built Farnham Facility

Cannara Biotech Inc. (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation, processing and medical sale of premium dried cannabis and cannabis derivatives under The Cannabis Act, recently announced the receipt of its cultivation license from Health Canada for Phase 1 of its purpose-built Farnham Facility, in Québec. "After many months of diligent preparation, today's milestone will allow us to start cultivation immediately and to advance our goal of becoming the premiere grower of cannabis in Québec and in due course, the rest of Canada," Cannara Biotech (Quebec) Inc. COO Barry Laxer said…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered